A Prospective Comparison of the 21-Gene Recurrence Score and the PAM50-Based Prosigna in Estrogen Receptor-Positive Early-Stage Breast Cancer
Crossref DOI link: https://doi.org/10.1007/s12325-015-0269-2
Published Online: 2015-11-26
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Alvarado, Michael D.
Prasad, Che
Rothney, Megan
Cherbavaz, Diana B.
Sing, Amy P.
Baehner, Frederick L.
Svedman, Christer
Markopoulos, Christos J.
Funding for this research was provided by:
Genomic Health